NCT02030847 · Interventional trial
Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia
Overall registry status Completed
Phase 2
Conditions Patients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment Options
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory